Fullerene Gallium Phosphonate Shows Antimycobacterial Effect Against Mycobacterium avium
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26209998 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sonyeol Yoon und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA. Hauptthemen laut MEDLINE: Fullerenes, Gallium, Anti-Bacterial Agents, Organophosphonates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, BSC Holdings USA Corporation.
Abstract (Originalsprache)
Mycobacterium avium complex (MAC) infections present significant therapeutic challenges due to their inherent antibiotic resistance, demanding innovative treatment approaches. This study investigated the antimicrobial and antioxidant potential of a novel compound, Fullerene Gallium Phosphonate (FGP), and compared its effects against a previously tested similar compound, Fullerene Disodium Phosphonate (FDSP). Results of experiments using MAC cultures and infected THP-1 macrophages treated with varying FGP and FDSP concentrations (1, 10, 100 µg/mL) revealed that FGP demonstrated greater efficacy than FDSP in reducing M. avium colony-forming units (CFU), achieving a nearly 3-fold reduction by day 8, compared to a 2-fold decrease with FDSP. In infected macrophages, FGP significantly decreased bacterial load at 1 and 10 µg/mL (p < 0.01). FGP also lowered oxidative stress, reflected by a significant reduction in malondialdehyde (MDA) levels on day 4 (p < 0.05) and decreased IL-6 (2-fold) and TNF-α levels (3-fold) by day 8, indicating both antimicrobial and anti-inflammatory effects. However, FGP paradoxically increased MAC burden at its highest concentration and showed no significant difference in efficacy of different concentrations. These findings suggest that FGP may serve as a promising candidate for antimycobacterial therapy with dual antibacterial and antioxidant effects. Further research is crucial to fully elucidate its mechanism of action and find the optimal therapeutic window.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
- College of Health Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.
- College of Dental Medicine, Western University of Health Sciences, Pomona, CA 91766, USA.
- Sinapu LLC, 6 Technology Dr., Irvine, CA 92618, USA.
ORCID-Profile: Sonyeol Yoon, Kayvan Sasaninia, Arshavir Karapetyan, Vishwanath Venketaraman
Förderung
- NHLBI NIH HHS
- BSC Holdings USA Corporation
Zitieren
APA
Yoon, S., Sasaninia, K., Era, I. H., Dhama, S., Mohan, A. S., Patel, A., Nguyen, L., Karapetyan, A., Sy, C., Yedgarian, N., Newman, N., Bi, X., Baudry, M., Yang, P. R., & Venketaraman, V. (2025). Fullerene Gallium Phosphonate Shows Antimycobacterial Effect Against Mycobacterium avium. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209998
Vancouver
Yoon S, Sasaninia K, Era IH, Dhama S, Mohan AS, Patel A, et al. Fullerene Gallium Phosphonate Shows Antimycobacterial Effect Against Mycobacterium avium. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209998
BibTeX
@article{Yoon2025,
author = {Yoon, Sonyeol and Sasaninia, Kayvan and Era, Iffat Hasnin and Dhama, Sanya and Mohan, Aishvaryaa Shree and Patel, Ami and Nguyen, Lannhi and Karapetyan, Arshavir and Sy, Cristian and Yedgarian, Nickolas and Newman, Nezam and Bi, Xiaoning and Baudry, Michel and Yang, Peter R and Venketaraman, Vishwanath},
title = {Fullerene Gallium Phosphonate Shows Antimycobacterial Effect Against Mycobacterium avium},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26209998}
}
EUVIMED